Australian Biotech nails $940m deal with US firm
MELBOURNE: ASX-listed Dimerix has landed one of the biggest licensing deals by an Australian biotechnology
MELBOURNE: ASX-listed Dimerix has landed one of the biggest licensing deals by an Australian biotechnology